REmote COnditioning in Out-of-Hospital Cardiac Arrest
RECO-OHCA
REmote Ischemic COnditioning in Out-of-Hospital Cardiac Arrest: The RECO-OHCA Study
2 other identifiers
interventional
220
1 country
14
Brief Summary
Out-of-Hospital Cardiac Arrest remains a major public health problem, resulting in high mortality largely related to multiple organ failure and poor neurological outcomes due to brain anoxia. The pathophysiology of organ dysfunction after resuscitated out-of-hospital cardiac arrest involves ischemia-reperfusion processes. Remote ischemic conditioning is a therapeutic strategy used to protect organs against the detrimental effects of ischemia-reperfusion injury. The objective of the present trial is to determine whether remote ischemic conditioning performed early after out-of-hospital cardiac arrest can decrease mortality, or multiple organ failure and/or severe neurological failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
Typical duration for not_applicable
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2024
CompletedFirst Posted
Study publicly available on registry
March 12, 2024
CompletedStudy Start
First participant enrolled
June 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 5, 2026
February 12, 2025
February 1, 2025
2 years
January 23, 2024
February 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
All cause of death
All-cause death will be assessed 72 hours after hospital admission.
72 hours after hospital admission
Multiple organ failure
Multiple organ failure is defined by a SOFA (Sepsis-related Organ Failure Assessment) score, censored for the neurological component, greater than or equal to 5.
72 hours after hospital admission
Severe neurological failure
Severe neurological failure is defined by a motor component of the Glasgow Coma Score less than or equal to 3, without confounding factors (hypothermia less than or equal to 35.0°C, and/or sedation/analgesia/curarization). The glasgow coma score ranges from 3 to 15 and is broken down into its three parameters: eye opening, verbal response and motor response. The higher the score, the better the patient's recovery.
72 hours after hospital admission
Secondary Outcomes (16)
Sepsis-related Organ Failure Assessment (SOFA) score
24 hours after hospital admission
Sepsis-related Organ Failure Assessment (SOFA) score
48 hours after hospital admission
Sepsis-related Organ Failure Assessment (SOFA) score
72 hours after hospital admission
Sepsis-related Organ Failure Assessment (SOFA) score after exclusion of the neurological sub-score
24 hours after hospital admission
Sepsis-related Organ Failure Assessment (SOFA) score after exclusion of the neurological sub-score
48 hours after hospital admission
- +11 more secondary outcomes
Study Arms (2)
Remote ischemic conditioning
EXPERIMENTALA brachial cuff is positioned around one arm of the patient. Remote ischemic conditioning consists of alternating inflations and deflations of the brachial cuff. Four cycles of ischemic conditioning (5-min brachial cuff inflation at 200 millimetres of mercury (mmHg) followed by 5-min cuff deflation) are started as soon as possible after inclusion. The intervention is repeated 12 and 24 hours after inclusion.
Control group
OTHERA brachial cuff is positioned around one arm of the patient. Neither inflation nor deflation is performed.
Interventions
A brachial cuff is positioned around one arm of the patient. Remote ischemic conditioning consists of four cycles of a 5-min brachial cuff inflation at 200 mmHg followed by a 5-min of cuff deflation, and is started as soon as possible after randomization. The intervention is repeated 12 and 24 hours after inclusion.
A brachial cuff is positioned around the arm of the patient and no inflation or deflation is performed.
Eligibility Criteria
You may qualify if:
- Age between 18 and 80 years old
- Out-of-hospital cardiac arrest, whatever the initial cardiac rhythm (shockable or non-shockable) or the duration of no-flow and low-flow,
- Presence of a witness who may or may not have started cardiopulmonary resuscitation, or patient seen alive in the 30 minutes prior to the cardiac arrest,
- Hospitalisation in critical care (intensive care unit or cardiac intensive care unit) for less than 3 hours,
- Informed consent obtained from a close relative (exceptionally from the patient himself if his condition permits) or, failing this, use of the emergency procedure by the investigator.
You may not qualify if:
- Traumatic cardiac arrest
- Patient on extracorporeal circulatory assistance
- Cardiac arrest for which continuation of resuscitation does not appear justified (unavoidable death, terminal stage of an irreversible disease, etc.)
- Contraindication of the use of brachial cuff on both arms (arteriovenous fistula, lymphoedema or severe peripheral vascular pathology, unstable humeral fracture, continuous infusion into an upper limb vein of an essential drug such as a catecholamine, radial arterial catheter for continuous invasive measurement of blood pressure)
- Pregnant, parturient, or breast-feeding women
- Patients deprived of their liberty by a judicial or administrative decision,
- Patients under legal protection (guardianship, curatorship),
- Patient not affiliated to a social security scheme or beneficiary of a similar scheme,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (14)
Hôpital Louis Pradel
Bron, 69500, France
Hôpital Gabriel Montpied, CHU de Clermont Ferrand
Clermont-Ferrand, 63000, France
Centre Jean Perrin, Clermont-Ferrand
Clermont-Ferrand, 69300, France
Hôpital F Mitterrand, CHU de Dijon
Dijon, 21079, France
Hôpital Albert Michallon, CHU de Grenoble
La Tronche, 38700, France
Hôpital Edouard Herriot
Lyon, 69003, France
Hôpital Saint-Joseph Saint-Luc
Lyon, 69007, France
Hôpital de la Timone, CHU de Marseille
Marseille, 13385, France
Hôpital lapeyronie, CHU de Montpellier
Montpellier, 34295, France
Hôpital Universitaire Carémeau
Nîmes, 30029, France
Hôpital Lariboisière, APHP, Réanimation Médicale et Toxicologique
Paris, 75010, France
Hôpital Lyon-Sud
Pierre-Bénite, 69310, France
Hôpital Nord, CHU de St Etienne
Saint-Priest-en-Jarez, 42270, France
Hôpital Nord-Ouest
Villefranche-sur-Saône, 69655, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 23, 2024
First Posted
March 12, 2024
Study Start
June 21, 2024
Primary Completion (Estimated)
June 24, 2026
Study Completion (Estimated)
October 5, 2026
Last Updated
February 12, 2025
Record last verified: 2025-02